Thats not something they do
Unlike older drugs, PP405 targets a metabolic pathway inside hair follicle stem cells, encouraging them to wake up and begin producing new hair again
Evaluation of 1.8 mg subcutaneous dosing of liraglutide in AD patients (ELAD) phase 2b data showed less significant outcomes
Two recent studies suggest that GLP-1 drugs could increase the risk of fragile bones in older adults
GLP-1 weight loss uses medications that act on glucagon-like peptide-1 pathways, which are involved in appetite, fullness, digestion, and blood sugar regulation
Looking more closely at people living with diabetes, a recent meta analysis of 11 randomized controlled trials found that GLP-1s significantly reduced both cardiovascular and kidney events (such as kidney failure)